February 12, 2018
2 min watch
Save

VIDEO: New class of therapies may offer neuroprotection, pressure lowering

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN FRANCISCO At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at the Byers Eye Institute at Stanford University, discusses new glaucoma therapies that show promise to not only lower IOP but also provide neuroprotection.